v3.26.1
Stockholders’ Deficiency (Tables)
3 Months Ended
Mar. 31, 2026
MEZZANINE EQUITY  
Schedule of warrant activity

 

   Number of
Warrants
   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining
Contractual
Term
(Years)
  

Weighted-
Average 

Grant-

Date Fair

Value

 
Outstanding and exercisable at January 1, 2026   243,323,017   $0.021    1.30   $1,963,079 
                     
Expired                
Outstanding and exercisable at March 31, 2026   243,323,017   $0.021    0.80   $1,963,079